However, HCC-associated mutations or pathologically low expression of SPOP lead to aberrant stabilization of LMNB2, which in turn, directly induces PD-L1 transcription, thereby promoting tumor immune evasion of HCC. This evidence concerns the gene LMNB2 and hepatocellular carcinoma.